The CRIC study cohort analysed adults with chronic kidney disease (CKD) after excluding those with heart failure at baseline. The study team reported that 161 participants — 4.5% of the analytic sample — developed progressive cardiorenal syndrome (CRS), defined as the emergence of both heart failure (HF) and end-stage kidney disease (ESKD) within a 12-month window. The cohort size and incidence number were provided in the abstract; the preprint emphasizes this as the principal outcome measure.
Investigators modeled baseline risk factors using Cox proportional hazards frameworks and reported several traditional predictors that retained association in multivariable analyses. Lower educational attainment carried an increased hazard [multivariable-adjusted HR reported in the abstract], and preexisting cardiovascular disease was linked to higher risk of developing progressive CRS. Markers of kidney health — specifically lower estimated glomerular filtration rate (eGFR) and higher albumin-to-creatinine ratio (albuminuria) — were strongly associated with progression to combined HF and ESKD. The abstract lists these associations with adjusted hazard ratios; the paper reports the point estimates and confidence intervals there.
The study team identified several biomarker signals not typically catalogued as ‘traditional’ cardiovascular risk factors. Higher levels of alkaline phosphatase and elevated brain natriuretic peptide (BNP) were associated with progressive CRS. Inflammatory and fibrotic mediators also appeared: tumor necrosis factor alpha (TNF-?) and growth differentiation factor 15 (GDF-15) were both reported as associated with the composite outcome. Laboratory indices related to metabolic control and oxygen-carrying capacity — higher hemoglobin A1c (HbA1c) and lower hemoglobin, respectively — were likewise linked to increased risk. The authors framed these as potentially novel or understudied risk markers in this population.
A sensitivity analysis examined the temporal order of organ failure: cases where HF preceded ESKD, and vice versa. The investigators observed overlapping and distinct patterns. Across both sequences, worse kidney function, albuminuria, markers of mineral bone disorder (higher alkaline phosphatase and parathyroid hormone [PTH]), inflammation (TNF-?), the fibrotic marker GDF-15, and anemia were associated with progression. When HF came first, the associations with diabetes, established cardiovascular disease, higher systolic blood pressure, greater waist circumference, HbA1c, and BNP strengthened according to the abstract. The preprint provides the comparative hazard estimates in its results tables.
The authors used Cox proportional hazards models to examine baseline predictors of progressive CRS, and the manuscript reports multivariable-adjusted hazard ratios for the factors named in the abstract. They performed a sensitivity analysis stratified by the order of HF and ESKD onset to assess whether associations differed when cardiac disease preceded renal replacement need versus the reverse. The CRIC data supporting the analyses are available by reasonable request, as noted in the Data Availability statement.
This preprint has not been peer reviewed; the authors explicitly stated that the report should not be used to guide clinical practice. The abstract does not list detailed limitations beyond that status. The manuscript did not report intervention data, treatment regimens, or causal inference methods beyond Cox modeling in the abstract; investigators reported associations rather than evidence of causation. The study did not provide randomized or interventional data to show that modifying the identified risk markers reduces progressive CRS incidence. Additional unanswered questions include how interventions targeting the identified biomarker pathways — inflammation, mineral bone disorder, anemia, and glycemic control — would alter risk, and whether the observed associations persist across broader CKD populations or in different clinical settings. These topics remain open for future peer-reviewed analyses or randomized studies.
The authors disclosed no competing interests, and institutional review boards at participating sites approved the CRIC protocol, according to the article declarations. For readers seeking the full statistical tables, model covariates, or subgroup estimates, the preprint and the CRIC data request process provide the sources to examine those details further.